Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake

Journal of Nuclear Medicine

Volumn 39, Issue 3, 1998, Pages 379-383

  Ng, Chin K ^a   Soufer, Robert ^b   McNulty, Patrick H ^b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Fluorine 18 fluorodeoxyglucose; Insulin; Lumped constant; Tracer kinetics

Indexed keywords

FATTY ACID; FLUORODEOXYGLUCOSE F 18; INSULIN; TRACER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CORONARY SINUS; DIET RESTRICTION; HEART CATHETERIZATION; HEART FUNCTION; HEART STIMULATION; HUMAN; HYPERINSULINEMIA; INSULIN INFUSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL;

AGED; FATTY ACIDS, NONESTERIFIED; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE CLAMP TECHNIQUE; HEART; HEART CATHETERIZATION; HUMANS; HYPERINSULINISM; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031906789     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. McGhie AI, Gould KL, Schelbert HR, Willerson JT. Coronary artery disease: nuclear cardiology. In: Willerson JT, Cohn JN, eds. Cardiovascular medicine. New York: Churchill Livingstone; 1995:475-527.
2. 18F]2-deoxy-2-fiuoro-D-glucose for the assessment of flux through metabolic pathways in heart muscle: a critical appraisal. In: Schwaiger M, ed. Cardiac positron emission tomography. Boston: Kluwer Academic; 1996:79-95.
3. Knuuti JM, Nuutila Pirjo, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33:1255-1262.
4. Rothley JM, Weeden ARJ. Clinical PET protocols. In: Schwaiger M, ed. Cardiac positron emission tomography. Boston: Kluwer Academic; 1996:355-364.
5. Crane PD, Pardridge WM, Braun LD, Oldendorf WH. Kinetics of transport and phosphorylation of 2-fluoro-2-deoxy-D-glucose in rat brain. J Neurochem 1983;40:160-167.
6. Bessell EM, Fosterr AB, Westwood JH. The use of deoxyfluoro-D-glucopyranoses and related compound in a study of yeast hexokinase specificity. Biochem J 1973;128: 199-204.
7. Opie LH, Newsholme EA. The activity of fructose 1,6 diphosphatase, fructokinase, and phosphoenolpyruvate carboxykinase in white and red muscle. Biochem J 1967; 103:391-399.
8. Ng CK, Holden JE, DeGrado TR, Raffel DM, Kornguth ML, Gatley SJ. Sensitivity of myocardial fluorodeoxyglucose lumped constant to glucose and insulin. Am J Physiol 1991;260:H593-H603.
9. 18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 1995;91:2435-2444.
10. Russell RR, Mrus JM, Mommesin JI, Taegtmeyer H. Compartmentation of hexokinase in rat heart: a critical factor for tracer kinetic analysis of myocardial glucose metabolism. J Clin Invest 1992;90:1972-1977.
11. Krivokapich J, Huang S-C, Selin CE, Phelps ME. Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. Am J Physiol 1987;252: H777-H787.
12. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982;23:577-586.
13. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238.
14. Padgett HC, Schmidt DG, Luxen A, Bida GT, Satyamurthy N, Barrio JR. Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. Appl Radial Isot 1989;40:433-445.
15. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
16. McNulty PH, Louard RJ, Deckelbaum LI, Zaret BL, Young LH. Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance. Circulation 1995;92:2151-2156.
17. Bergmeyer H, ed. Methods of enzymatic analysis, 3rd ed. New York: Springer-Verlag; 1978:1196-1201.
18. Barrett EJ, Schwartz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest 1984;74:1073-1079.
19. Cunningham VJ, Cremer JE. Current assumptions behind the use of PET scanning for measuring glucose utilization in brain. Trends Neurosci 1985;8:96-99.
20. Kennedy C, Sakurada O, Shinohara M, et al. Local cerebral glucose utilization in the normal conscious macaque monkey. Ann Neurol 1978;4:293-301.
21. Bøtker HE, Böttcher M, Schmitz O, et al. Mechanisms for regulation of myocardial glucose uptake is described by variability of the lumped constant. Circulation 1995;92:(suppl 1):I-313.
22. 18F]fluorodeoxyglucose. J Cereb Blood Flow Metab 1990;10:180-189.
23. 14C]deoxyglucose technique. J Cereb Blood Flow Metab 1992;12:70-77.
24. 14C]deoxyglucose as markers of glycolysis in reperfused myocardium. Cir Res 1992;71:689-700.
25. 31P NMR study. J Mol Cell Cardiol 1991;23:1101-1115.
26. Ferrannini E, Santoro D, Bonadonna R, Natali A, Parodi O, Camici PG. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol 1993;264:E308-E315.